The FIT40 Podcast cover image

#159: How To Get The Best Results On GLP-1 Agonists (Semaglutide, Ozempic, Tirzepatide, etc.) w/ Dr. Gabby Gerbino

The FIT40 Podcast

00:00

Understanding GLP-1 Agonists and Obesity Management

This chapter explores GLP-1 agonists like semaglutide and terzepatide, focusing on their role in managing diabetes and aiding weight loss. It discusses the importance of dosage management, side effects, and eating habits while highlighting obesity as a chronic disease that warrants ongoing treatment. The conversation also addresses the challenges of insurance coverage and the implications of controversial marketing strategies for weight loss medications.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app